跳至主要内容
临床试验/NCT04395274
NCT04395274已完成不适用

Young Adult EC Use and Respiratory Outcomes

Ohio State University Comprehensive Cancer Center1 个研究点 分布在 1 个国家目标入组 115 人开始时间: 2021年12月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
115
试验地点
1
主要终点
Spirometry to Measure the Change From Baseline in Forced Vital Capacity (FVC)

研究概览

简要总结

E-cigarette (EC) use continues to increase among youth, and EC may be detrimental to youth respiratory health. Public health officials and the Food and Drug Administration (FDA) can now regulate ECs. The proposed study uses naturalistic assessments called ecological momentary assessment (EMA) to understand how ECs use may impact the respiratory health of youth and young adult users compared to never-using peers.

详细描述

Using a prospective longitudinal design, 150 youth and young adults aged 18-25 years (100 exclusive-EC users; 50 never-users) will complete 5 sessions (baseline, 3-,6-, 9-, and 12-months). Sessions will include naturalistic measures such as measures of respiratory health, questionnaires, and nasal epithelial lining fluid (NELF) nasal samples. To assess acute changes in pulmonary functioning related to tobacco product use, participants will complete twice daily EMA and home-based spirometry for the 2 weeks following the Day 1 session and the 2 weeks prior to each follow-up zoom session. Never-users will participate in a brief 15-30-minute individual interview consisting of questions related to reasons for never-EC use and other protective factors that will be used to build future prevention messaging.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 25 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • own a smartphone and willing to add study EMA and spirometry application to it.
  • a current exclusive-EC user (endorse ≥weekly use over the past 3 months) and report never trying OTPs
  • between the ages of 18-25 years old at the time of enrollment
  • read and speak English
  • willing to complete five, 2-week periods of daily EMA and home-based spirometry
  • never-users must indicate never trying any tobacco product to be eligible for enrollment

排除标准

  • self-reported diagnosis of lung disease including cystic fibrosis or chronic obstructive pulmonary disease; we will not exclude youth who have asthma, but will incorporate this as a covariate during analyses
  • unstable or significant psychiatric conditions (past and stable conditions will be allowed)
  • history of cardiac event or distress within the past 3 months
  • are currently pregnant, planning to become pregnant, or breastfeeding
  • are blind, severely visually impaired, deaf, hard of hearing, or have a severe motor disability

结局指标

主要结局

Spirometry to Measure the Change From Baseline in Forced Vital Capacity (FVC)

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Participants will complete twice daily home-based spirometry (a pulmonary function diagnostic test) for the 2 weeks prior to each follow-up session.

Spirometry to Measure the Change From Baseline in Forced Expiratory Volume (FEV)

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Participants will complete twice daily home-based spirometry (a pulmonary function diagnostic test) for the 2 weeks prior to each follow-up session.

Level of Dependence by Product Type Will be Examined.

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Changes in product use evaluated with an evaluation of the changes in dependence using the Hooked on Nicotine Checklist (HONC). Scores range from 0 to 10 with higher values indicating greater levels of dependence.

Respiratory Health Measures by Nasal Swab - IL-6

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Nasal epithelial lining fluid (NELF) samples will provide objective data on respiratory health (e.g., markers of inflammation, host defense, and lung injury) and will provide estimates of nicotine exposure/use via cotinine (i.e., the predominate metabolite of nicotine).

Respiratory Health Measures by Nasal Swab - IL-8

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Nasal epithelial lining fluid (NELF) samples will provide objective data on respiratory health (e.g., markers of inflammation, host defense, and lung injury) and will provide estimates of nicotine exposure/use via cotinine (i.e., the predominate metabolite of nicotine) will also be examined to provide objective indicators of recency of EC and/or OTP use.

Respiratory Health Measures by Nasal Swab - TNF-alpha

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Nasal epithelial lining fluid (NELF) samples will provide objective data on respiratory health (e.g., markers of inflammation, host defense, and lung injury) and will provide estimates of nicotine exposure/use via cotinine (i.e., the predominate metabolite of nicotine) will also be examined to provide objective indicators of recency of EC and/or OTP use.

Respiratory Health Measures by Nasal Swab - IL-4

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Nasal epithelial lining fluid (NELF) samples will provide objective data on respiratory health (e.g., markers of inflammation, host defense, and lung injury) and will provide estimates of nicotine exposure/use via cotinine (i.e., the predominate metabolite of nicotine) will also be examined to provide objective indicators of recency of EC and/or OTP use.

Respiratory Health Measures by Nasal Swab - IL-5

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Nasal epithelial lining fluid (NELF) samples will provide objective data on respiratory health (e.g., markers of inflammation, host defense, and lung injury) and will provide estimates of nicotine exposure/use via cotinine (i.e., the predominate metabolite of nicotine) will also be examined to provide objective indicators of recency of EC and/or OTP use.

Respiratory Health Measures by Nasal Swab - IL-10

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Nasal epithelial lining fluid (NELF) samples will provide objective data on respiratory health (e.g., markers of inflammation, host defense, and lung injury) and will provide estimates of nicotine exposure/use via cotinine (i.e., the predominate metabolite of nicotine) will also be examined to provide objective indicators of recency of EC and/or OTP use.

Respiratory Health Measures by Nasal Swab - IL-13

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Nasal epithelial lining fluid (NELF) samples will provide objective data on respiratory health (e.g., markers of inflammation, host defense, and lung injury) and will provide estimates of nicotine exposure/use via cotinine (i.e., the predominate metabolite of nicotine) will also be examined to provide objective indicators of recency of EC and/or OTP use.

Respiratory Health Measures by Nasal Swab - TARC

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Nasal epithelial lining fluid (NELF) samples will provide objective data on respiratory health (e.g., markers of inflammation, host defense, and lung injury) and will provide estimates of nicotine exposure/use via cotinine (i.e., the predominate metabolite of nicotine) will also be examined to provide objective indicators of recency of EC and/or OTP use.

Respiratory Health Measures by Nasal Swab - Eotaxin

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Nasal epithelial lining fluid (NELF) samples will provide objective data on respiratory health (e.g., markers of inflammation, host defense, and lung injury) and will provide estimates of nicotine exposure/use via cotinine (i.e., the predominate metabolite of nicotine) will also be examined to provide objective indicators of recency of EC and/or OTP use.

Respiratory Health Measures by Nasal Swab - MCP-1

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Nasal epithelial lining fluid (NELF) samples will provide objective data on respiratory health (e.g., markers of inflammation, host defense, and lung injury) and will provide estimates of nicotine exposure/use via cotinine (i.e., the predominate metabolite of nicotine) will also be examined to provide objective indicators of recency of EC and/or OTP use.

Respiratory Health Measures by Nasal Swab - MCP-4

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Nasal epithelial lining fluid (NELF) samples will provide objective data on respiratory health (e.g., markers of inflammation, host defense, and lung injury) and will provide estimates of nicotine exposure/use via cotinine (i.e., the predominate metabolite of nicotine) will also be examined to provide objective indicators of recency of EC and/or OTP use.

Respiratory Health Measures by Nasal Swab - Cotinine

时间窗: Baseline, 3-month, 6-month, 9-month, 12-month

Nasal epithelial lining fluid (NELF) samples will provide objective data on respiratory health (e.g., markers of inflammation, host defense, and lung injury) and will provide estimates of nicotine exposure/use via cotinine (i.e., the predominate metabolite of nicotine) will also be examined to provide objective indicators of recency of EC and/or OTP use.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alayna Tackett

Assistant Professor

Ohio State University Comprehensive Cancer Center

研究点 (1)

Loading locations...

相似试验

Young Adult EC Use and Respiratory Outcomes | 临床试验